Table 4. Multivariate Cox regression analysis including clinical variables for high stage ccRCC (n=40) with Progression Free Survival as endpoint.

Variables	Univariate analysis	Multivariate analysis
ccRCC	p-value	HR	95 % CI	p-value
CK2α Nuc+ expression	0.043*	5.19	0.64-42.3	0.124
Fuhrman (G3+G4)	0.03*	4.79	1.41-16.28	0.012*
Tumorsize ≥ 7 cm	0.21	2.57	0.81-8.2	0.111
Female	0.07	3.42	1.05-11.07	0.04*
VHL mutation	0.64	1.24	0.45-3.45	0.68

^*p <0.05